Famotidine is indicated for the treatment of conditions where reduction of gastric secretion is needed, including treatment of gastric and duodenal ulcers, gastroesophageal reflux disease and Zollinger-Ellison syndrome. Famotidine Tablets are also used for the prevention and treatment of heartburn and hyperacidity in the upper gastrointestinal tract.
Unipharm’s generic Famotidine Tablets have been manufactured and marketed in Israel since 1993.
Famotidine Tablets can replace Ranitidine and Cimetidine.
Unipharm’s EU Dossier of generic Famotine Tablets is offered with a new EU bioequivalence study compared to the EU Reference Listed Drug, Pepcid.